le 21 décembre 2021

After a year of absolute uncertainty, micro-predictions and near constant recalculations, the picture of our world and what’s next in it is becoming clearer. 

If there’s one through line in this year’s report, it’s this: we are an industry working toward sustainable acceleration in the product management lifecycle. The disruption of the pandemic fueled fast-moving innovation, including untold experience cycles that showed leaders what was possible in a crisis.   

So, what worked and what didn’t? What’s repeatable and important in the now normal?

There are several key themes leading us to what’s next and they start in a critically important place: new models across the spectrum from clinical development to commercialization and everything in between. Biopharma organizations around the world are validating provisional insights hard-earned in times of rapid change to identify exactly how to best achieve efficiency and effectiveness going forward. 

 

Looking for Exclusive Insight?

Complete the form below to download the full report and subscribe to our monthly email to receive exclusive updates on the 2022 Health Trends.

Scroll to Page Bottom Form 
Enabled 
Powered by Translations.com GlobalLink OneLink Software